[Correlation between single nucleotide polymorphisms of rs4778137 located in OCA2 gene and clinical response of breast cancer patients receiving neoadjuvant chemotherapy].

Guo, J Q; Wang, S; Zhou, W J; Xu, B L; Chen, L T

Guo, J Q; Wang, S; Zhou, W J; Xu, B L; Chen, L T.

Affiliation

Guo JQ; Department of Emergency, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Wang S; Department of Thyroid and Breast Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Zhou WJ; Department of Thyroid and Breast Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Xu BL; Department of Biological Treatment, Henan Cancer Hospital, Zhengzhou 450000, China.
Chen LT; Department of Emergency Medicine, Kaifeng City Center Hospital, Kaifeng 475000, China.

Zhonghua Yi Xue Za Zhi ; 99(22): 1712-1716, 2019 Jun 11.

Article in Zh | MEDLINE | ID: mdl-31216817

Subject(s)

Breast Neoplasms; Membrane Transport Proteins/genetics; Alleles; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms/genetics; Breast Neoplasms/therapy; Humans; Neoadjuvant Therapy; Polymorphism, Single Nucleotide; Receptor, ErbB-2; Treatment Outcome

Key words

Breast cancer; Neoadjuvant chemotherapy; OCA2; Pathologic complete response; Rs4778137; Single nucleotide polymorphisms

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Membrane Transport Proteins / Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: Zh Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google